Symatix – Synthetic Amniotic Membrane
We are developing an innovative synthetic amniotic membrane substitute. Click here to find out more.
Integrated Risk Management in Biomaterials Design and Manufacture
The Electrospinning Company was invited into the BIORIMA European H2020 funded project as an industrial partner due to their experience in the design, development, and manufacture of nanoscale biomaterials. As a member of the BIORIMA consortium, The Electrospinning Company contributed to the development of the Integrated Risk Management (IRM) framework and is now applying it… Read more »
Electrospinning in Orthopaedics
Read this article where we explore the use of electrospun materials in Orthopaedics.
£4.5M Investment Led by Confluent Medical
Proceeds to be used to expand electrospinning capabilities & capacity, driving company growth Harwell, UK, May 4 2021 – The Electrospinning Company (Electrospinning), a leader in the development and manufacture of nanofibrous biomaterials for use in tissue regenerative devices, has completed a £4.5m ($6.3m) fundraising round, led by US materials science company Confluent Medical Technologies Inc. (Confluent) as a strategic investor…. Read more »
Corneal Case Study
Read how close partnership with our client helped overcome technological & pandemic challenges.
Medica 2023, Düsseldorf – Germany 13-16 November 2023
The Electrospinning Company will attend Medica 2023 in Düsseldorf – Germany from 13 to 16 November 2023. Katrina Moisley, Nanayaa Bates and Conan Campbell are delighted to meet you talking about the latest on our stent cover technology and our innovative electrospinning method. For more information about our recent collaboration and successes please follow this… Read more »
Senior BD hires at The Electrospinning Company to drive growth in key areas. Executives bring more than 30 years’ experience in global medical device companies
Harwell, UK, September 12th, 2023 – The Electrospinning Company, a leading contract research, development and manufacturing organisation for electrospun biomaterials in medical devices, is driving its international expansion with the appointment of two senior business development executives. Conan Campbell, who joins as Senior Director of Business Development, is a specialist in vascular implant coatings. North… Read more »
Innovative Collaboration Elevates Coronary Stent Performance: A Milestone Achievement
We are proud to share the success story of a collaborative effort that is transforming the potential of coronary stent devices. The Electrospinning Company is collaborating with Relisys Medical Devices, one of the world’s largest manufacturers of highly innovative cardiovascular medical devices, to develop innovative products which could advance cardiovascular care and revolutionize patient outcomes…. Read more »
A Production Technician Intern Journey at TECL
Kinga is currently pursuing a Bachelor of Engineering degree in Medical Engineering at Swansea University in Wales. During her industry placement, she was working as a Production Technician Intern at The Electrospinning Company, where she gained valuable experience in the area of biomaterials science and engineering. As a Production Technician, she collaborated closely with the… Read more »
Medica 2023, Düsseldorf – Germany 13-16 November 2023
The Electrospinning Company will attend Medica 2023 in Düsseldorf – Germany from 13 to 16 November 2023. Katrina Mosely and Nanayaa Bates are delighted to meet you talking about the latest on our stent cover technology and our innovative electrospinning method. For more information about our recent collaboration and successes please follow this link Book… Read more »
Ever Congress, Valencia – Spain , October 2023
The Electrospinning Company is delighted to announce its participation in the upcoming EVER Congress scheduled for 26-28 October 2023. During the event, the University of Nottingham will be presenting our ground-breaking Symatix® Membrane in a research paper titled: “A Comparative In Vitro Study: Introducing a Biosynthetic Alternative to Human Amniotic Membrane for Cornea Repair.” This… Read more »
MedTech Ireland Conference, September 2023.
The Electrospinning Company is exhibiting at MedTech Ireland Conference in September 2023. You are welcome to visit our booth #98B and talk about electrospun biomaterials for medical devices and regenerative medicine.
Non-Woven Stent Coating Technology – No Future for the Suture?
Over the last 12 months at The Electrospinning Company, huge developments have been made in our sutureless stent coating technology platform. Cardiovascular stents covered with textiles and films have known advantages over uncovered ones, primarily that the coating provides a direct barrier to tissue ingrowth to prevent restenosis. Current manufacturing processes use sutures to stitch a textile… Read more »
The Electrospinning Company and Bionicia Fluidnatek further strengthen their collaboration
The Electrospinning Company and Bioinicia Fluidnatek collaborate to provide the medical device industry with unmatched levels of process development and manufacturing capability for electrospun materials and implantable devices. ELECTROSPINNING uses the FLUIDNATEK® electrospinning and electrospraying equipment platform for its biomaterial development and for its custom design, development, and manufacturing services. ELECTROSPINNING & FLUIDNATEK have been… Read more »
Non-Woven Solutions in Dental Surgery
We visited the International Dental Show (IDS) show, Cologne in March 2023 to explore the use of electrospun membranes for bone tissue guide repair dental membranes. This is what we learnt: Studies have shown that decellularized collagen outperforms synthetic fibrous non-woven membranes, and synthetics are only used if patients request for them, for example to… Read more »
Our approach in covering technology
We deposit fibrous membranes directly onto metal and non-metal devices, using expertise that we have gained over a decade of producing innovative non-woven medical textiles. We select from a wide range of GMP-grade degradable or non-degradable polymers to tailor a medical textile covering to a customer’s device. Both external and internal surfaces can be coated… Read more »
BioMed Israel | May 16 – 18, 2023
Meet our CEO, Ann Kramer, at the BioMed Israel conference. The Electrospinning Company designs, develops and manufactures nanofibrous biomaterials for medical devices and regenerative medicine. To find out more about who we are, please visit our website: https://www.electrospinning.co.uk/about-us/company/ To book a meeting with our CEO, contact us at: info@electrospinning.co.uk
